Cooper Other Non-Current Liabilities 2010-2024 | COO

Cooper other non-current liabilities from 2010 to 2024. Other non-current liabilities can be defined as field containing the sum of all non-current liabilities that cannot be standardized into another field as well as those that are aggregated by the company because materially, they are too small to list separately.
  • Cooper other non-current liabilities for the quarter ending July 31, 2024 were $0.336B, a 271.27% increase year-over-year.
  • Cooper other non-current liabilities for 2023 were $0.329B, a 2.66% decline from 2022.
  • Cooper other non-current liabilities for 2022 were $0.338B, a 142.41% increase from 2021.
  • Cooper other non-current liabilities for 2021 were $0.14B, a 13.83% decline from 2020.
Cooper Annual Other Non-Current Liabilities
(Millions of US $)
2023 $329
2022 $338
2021 $140
2020 $162
2019 $125
2018 $142
2017 $
2016 $
2015 $
2014 $
2013 $
2012 $
2011 $
2010 $
2009 $
Cooper Quarterly Other Non-Current Liabilities
(Millions of US $)
2024-07-31 $336
2024-04-30 $337
2024-01-31 $370
2023-10-31 $329
2023-07-31 $91
2023-04-30 $91
2023-01-31 $112
2022-10-31 $338
2022-07-31 $117
2022-04-30 $126
2022-01-31 $138
2021-10-31 $140
2021-07-31 $140
2021-04-30 $150
2021-01-31 $165
2020-10-31 $162
2020-07-31 $162
2020-04-30 $159
2020-01-31 $176
2019-10-31 $125
2019-07-31 $125
2019-04-30 $125
2019-01-31 $125
2018-10-31 $142
2018-07-31 $171
2018-04-30 $176
2018-01-31 $176
2017-10-31
2017-07-31
2017-04-30
2017-01-31
2016-10-31
2016-07-31
2016-04-30
2016-01-31
2015-10-31
2015-07-31
2015-04-30
2015-01-31
2014-10-31
2014-07-31
2014-04-30
2014-01-31
2013-10-31
2013-07-31
2013-04-30
2013-01-31
2012-10-31
2012-07-31
2012-04-30
2012-01-31
2011-10-31
2011-07-31
2011-04-30
2011-01-31
2010-10-31
2010-07-31
2010-04-30
2010-01-31
2009-10-31
2009-07-31
2009-04-30
2009-01-31
Sector Industry Market Cap Revenue
Medical Medical & Dental Supplies $19.898B $3.593B
The Cooper Companies Inc, is a specialty medical device company operating on a global basis. Cooper has two business segments- CooperVision and CooperSurgical. CooperVision manufactures and sells a wide range of contact lenses. CooperVision develops manufactures and markets a broad range of single-use, two-week and monthly contact lenses, featuring advanced materials and optics. The company's products are primarily designed for solving vision challenges like astigmatism, presbyopia and ocular dryness.?CooperSurgical sells a variety of medical devices and surgical instruments that are primarily utilized by gynecologists and obstetricians.
Stock Name Country Market Cap PE Ratio
McKesson (MCK) United States $79.753B 21.76
Becton Dickinson (BDX) United States $65.165B 17.13
Cardinal Health (CAH) United States $29.869B 16.20
West Pharmaceutical Services (WST) United States $23.239B 47.47
Labcorp (LH) United States $20.088B 16.66
Align Technology (ALGN) United States $17.037B 32.60
Henry Schein (HSIC) United States $9.198B 17.52
Merit Medical Systems (MMSI) United States $6.121B 31.26
DENTSPLY SIRONA (XRAY) United States $3.705B 10.08
CONMED (CNMD) United States $2.215B 18.48
Patterson (PDCO) United States $1.788B 9.43
STAAR Surgical (STAA) United States $1.312B 48.42
Lifevantage (LFVN) United States $0.165B 21.93
Pro-Dex (PDEX) United States $0.138B 27.49